Rumeysa Colak

13PUBLICATIONS
115CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 08, 2026
Prognostic value of CT-measured baseline tumor volume in nivolumab-treated metastatic renal cell carcinoma.

|Aug 26, 2026
Prognostic Value of BMI in Patients with Metastatic Cervical Cancer:A Retrospective Study From Turkey.

|May 04, 2026
Serum Carcinoembryonic Antigen Levels Across Molecular Subtypes and Their Clinical and Prognostic Implications in Metastatic Non-Small Cell Lung Cancer.

|Mar 28, 2026
Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.

Sedat Yıldız, Hacer Demir, Talha Özüdoğru

|Jul 30, 2025
Pathologic Response and Survival Outcomes on HER2-Low vs. HER2-Zero in Breast Cancer Receiving Neoadjuvant Chemotherapy.

Rumeysa Colak, Caner Kapar, Ezgi Degerli

|Jul 12, 2025
First-Line Chemotherapy Versus CDK4/6 Inhibitors in HR-Positive, HER2-Negative Breast Cancer with Liver Metastases: A Multicenter Real-World Data.

Mehmet Cem Fidan, Ahmet Emin Öztürk, Okan Aydın

Pageof 3

Frequent Collaborators

11 joint publications

Mesut Yılmaz

5 joint publications

Caner Kapar

5 joint publications

Nargiz Majıdova

4 joint publications

Özkan Alan